Although IL-6 is a useful biomarker and diagnostic indicator of sepsis progression66,67, the administration of anti-IL-6 or anti-IL-6R therapy for the treatment of sepsis has not been studied because IL-6 is an important factor driving immune activation as a host defense against infection. The gene discussed is IL6R; the disease is Sepsis.